Showing results (741-750 of 1,050) with videos related to

Sort By:
Pageof 105
Critical Care (London, England)|December 22, 2014
Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trialGeorg Fuernau, Janine Pöss, Daniel Denks, et al.
European Journal of Heart Failure|December 11, 2019
Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EMPA-REG OUTCOME trialMichael Böhm, Jonathan Slawik, Martina Brueckmann, et al.
European Journal of Heart Failure|January 20, 2015
Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trialStephen J Greene, Aldo P Maggioni, Gregg C Fonarow, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 4, 2022
Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registryRoland E Schmieder, Felix Mahfoud, Giuseppe Mancia, et al.
Circulation|March 17, 2010
Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) TrialsMichael Böhm, Magnus Baumhäkel, Koon Teo, et al.
Circulation|April 27, 2011
Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot studyFelix Mahfoud, Markus Schlaich, Ingrid Kindermann, et al.
European Journal of Preventive Cardiology|November 30, 2017
Marathon running increases circulating endothelial- and thrombocyte-derived microparticlesViktoria Schwarz, Philip Düsing, Thomas Liman, et al.
European Journal of Heart Failure|September 16, 2025
Heart failure outcomes and empagliflozin effects in patients with heart failure and reduced ejection fraction in sinus rhythm or atrial fibrillation: Data from EMPEROR-ReducedMichael Böhm, Javed Butler, Amr Abdin, et al.
JACC. Heart Failure|March 15, 2025
Stroke in Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis of Randomized TrialsGuglielmo Gallone, Federica Savoca, Davide Miccoli, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 10, 2007
Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathyAngela Kallwellis-Opara, Alexander Staudt, Christiane Trimpert, et al.
Pageof 105